Outcomes of a Comprehensive Pain Rehabilitation Program for Patients With Fibromyalgia.
CESD, Center for Epidemiological Studies–Depression Scale
CSS, central sensitization syndrome
FM, fibromyalgia
MCPRP, Mayo Clinic Comprehensive Pain Rehabilitation Program
MPI, Multidimensional Pain Inventory
NO, no opioids on admission
NSAID, nonsteroidal anti-inflammatory drug
OME, oral morphine equivalent
OP, opioids on admission
PCS, Pain Catastrophizing Scale
PSEQ, Pain Self-Efficacy Questionnaire
SF-36, 36-Item Short-Form Health Status Survey
SS, Symptom Severity Scale
WPI, Widespread Pain Index
Journal
Mayo Clinic proceedings. Innovations, quality & outcomes
ISSN: 2542-4548
Titre abrégé: Mayo Clin Proc Innov Qual Outcomes
Pays: Netherlands
ID NLM: 101728275
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
epublish
Résumé
To analyze opioid intake interference with psychological, well-being, and functional outcomes and medication tapering in patients with fibromyalgia admitted to the Mayo Clinic Pain Rehabilitation Program (MCPRP) in Florida. A retrospective study on MCPRP outcomes was conducted. We reviewed the health records of 150 patients with fibromyalgia who participated in the program from May 1, 2014, to May 1, 2015. All patients were asked to fill out a survey at admission to and dismissal from the program. Surveys contained questions from the numeric pain score, Multidimensional Pain Inventory (perceived life control and interference of pain subscales), Center for Epidemiological Studies-Depression Scale, Pain Catastrophizing Scale, 36-Item Short-Form Health Status Survey (general health perceptions subscale), and Pain Self-Efficacy Questionnaire. A medical record review identified categories and number of medications at program admission and dismissal. Patients were divided in 2 groups: those whose concomitant medication did not include opioids at admission (no opioids group) and those whose concomitant medication included opioids at admission (opioids group). By dismissal from the MCPRP, patients with fibromyalgia in the no opioids group had a significant ( Benefit of the comprehensive pain rehabilitation program in patients with fibromyalgia was indicated by clinical improvements in pain severity, physical and emotional health, and functional capacity while successfully tapering medication. Opioid intake at admission may modify the program outcomes.
Identifiants
pubmed: 34820597
doi: 10.1016/j.mayocpiqo.2021.08.008
pii: S2542-4548(21)00127-2
pmc: PMC8601967
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1056-1065Informations de copyright
© 2021 THE AUTHORS.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Pain Med. 2015 Mar;16(3):472-9
pubmed: 25280054
Autoimmun Rev. 2018 Jan;17(1):33-35
pubmed: 29108831
J Rheumatol. 2010 Oct;37(10):1991-2005
pubmed: 20682676
Psychosomatics. 2000 Mar-Apr;41(2):104-13
pubmed: 10749947
J Can Chiropr Assoc. 2018 Apr;62(1):26-41
pubmed: 30270926
PLoS One. 2019 Feb 6;14(2):e0210701
pubmed: 30726245
Pain. 2008 Nov 15;140(1):177-189
pubmed: 18804915
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
Arthritis Rheum. 2005 Apr;52(4):1264-73
pubmed: 15818684
Pain Med. 2018 Feb 1;19(2):385-392
pubmed: 28402524
Cleve Clin J Med. 2009 Apr;76(4):255-61
pubmed: 19339642
J Behav Med. 2000 Aug;23(4):351-65
pubmed: 10984864
Brain. 2013 Jun;136(Pt 6):1857-67
pubmed: 23474848
Neuroscientist. 2011 Apr;17(2):209-20
pubmed: 21489967
Rheumatol Int. 2020 Jun;40(6):849-858
pubmed: 31900502
Brain. 2004 Apr;127(Pt 4):835-43
pubmed: 14960499
Rheumatology (Oxford). 2020 Oct 1;59(10):3042-3049
pubmed: 32206792
Semin Arthritis Rheum. 2011 Dec;41(3):319-34
pubmed: 21665248
PLoS One. 2018 Sep 13;13(9):e0203755
pubmed: 30212526
Lancet. 2017 May 6;389(10081):1778-1780
pubmed: 28495154
J Gen Intern Med. 2014 Mar;29(3):491-9
pubmed: 24165926
Psychosom Med. 1997 Nov-Dec;59(6):565-71
pubmed: 9407573
Mediators Inflamm. 2020 Sep 12;2020:2076328
pubmed: 33005097
Clin J Pain. 2004 Sep-Oct;20(5):348-56
pubmed: 15322442
J Gen Intern Med. 2007 Jun;22(6):818-21
pubmed: 17503107
Pain. 2014 Aug;155(8):1492-1503
pubmed: 24792477
J Sleep Res. 2020 Dec;29(6):e13020
pubmed: 32126156
J Pain. 2019 Jun;20(6):611-628
pubmed: 30453109
Pain Res Treat. 2016;2016:7217684
pubmed: 27242925
Pain. 1985 Dec;23(4):345-356
pubmed: 4088697
Clin J Pain. 2001 Mar;17(1):52-64
pubmed: 11289089
Subst Abuse Rehabil. 2010 Dec;2010(1):13-22
pubmed: 21709734
Pain Pract. 2020 Jan;20(1):62-74
pubmed: 31376331
Eur J Pain. 2007 Feb;11(2):153-63
pubmed: 16446108
PM R. 2012 May;4(5):355-66
pubmed: 22342820
Mayo Clin Proc. 2015 May;90(5):680-92
pubmed: 25939940
Neurobiol Dis. 1998 Oct;5(4):209-27
pubmed: 9848092
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
J Affect Disord. 2011 Feb;128(3):262-6
pubmed: 20674985
Lancet. 1999 Sep 11;354(9182):936-9
pubmed: 10489969
Mayo Clin Proc. 2011 Sep;86(9):907-11
pubmed: 21878603
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Clin J Pain. 2001 Jun;17(2):165-72
pubmed: 11444718
Pain Med. 2016 Sep;17(9):1676-85
pubmed: 26755658
J Pain Res. 2018 Sep 04;11:1715-1728
pubmed: 30233229
J Clin Rheumatol. 2021 Aug 1;27(5):187-193
pubmed: 32040055
Clin J Pain. 1997 Jun;13(2):163-70
pubmed: 9186024
Pain. 2017 Jan;158(1):34-47
pubmed: 27583567
Semin Arthritis Rheum. 2016 Dec;46(3):319-329
pubmed: 27916278
Pain Res Treat. 2012;2012:486590
pubmed: 22191023
Clin Exp Rheumatol. 2020 Jan-Feb;38 Suppl 123(1):72-78
pubmed: 32116211
Pain Pract. 2020 Jan;20(1):44-54
pubmed: 31336019
Pain. 1994 Dec;59(3):377-384
pubmed: 7708412
Pain. 2009 Sep;145(1-2):69-81
pubmed: 19539427
Pain Med. 2015 May;16(5):898-904
pubmed: 25645237
J Psychosom Res. 2010 May;68(5):415-26
pubmed: 20403500
Nat Rev Rheumatol. 2013 Dec;9(12):751-5
pubmed: 23820862
Pain. 2004 May;109(1-2):94-102
pubmed: 15082130
J Orthop Sports Phys Ther. 2020 Nov;50(11):592-596
pubmed: 33131390
Holist Nurs Pract. 2015 Jul-Aug;29(4):190-3
pubmed: 26086462
Arthritis Care Res. 1996 Apr;9(2):97-104
pubmed: 8970267
Ann Intern Med. 1999 Jun 1;130(11):910-21
pubmed: 10375340
PM R. 2011 Dec;3(12):1116-25
pubmed: 22192321